IMMUNOR

Immunor AS is a Norwegian-based vaccine developer unlike any other. Building on comprehensively patented IP of unique elegance and power, Immunor AS is in consequence capable of great agility and precision - hence safety - in its vaccine designs. Its core Mode of Action was most recently and sensationally validated during the Covid pandemic. Originally formed as a diagnostics company in the mid-1980s, Immunor AS as it is today is the result of more than 25 years' experience in the development of peptide-based vaccine technologies built on the Immunor CPSPVP (Cell Penetrating Selective Peptide Vaccine Platform) which provides a uniquely powerful platform for safe and efficacious vaccines... What distinguishes Immunor's offering from other traditional and new platforms such as Adenovirus and mRNA vectors is the design principle which underpins the CPSPVP. The CPSPVP Mode of Action is of a unique molecular peptide vaccine platform created through the use of an array of sequential..

Also known as: Immunor AS

Primary location: Oslo Norway